German researchers have identified a hypermetabolic phenotype in senescent tumor cells that exerts tumorigenic effects on other cells in the tumor microenvironment. Although small molecule inhibitors of the phenotype improved survival in a mouse model of lymphoma, future studies will need to determine whether the phenotype occurs in primary tumors.